Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LYSET pseudogene 1 (LYSETP1) is a pseudogene, meaning it is a DNA sequence that resembles a functional gene (in this case, the LYSET gene) but has lost its ability to code for a functional protein due to accumulated mutations[2][6][8]. Pseudogenes like LYSETP1 are generally considered nonfunctional and do not have known roles in protein production or biological pathways[2][6][7]. There is no evidence that LYSETP1 is involved in disease or serves as a biomarker or drug target. Its name indicates its origin as a “pseudogene” related to the LYSET (Lysosomal enzyme trafficking factor) gene, but it does not encode a functional product or serve any documented physiological function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LYSET pseudogene 1 (LYSETP1).